🇺🇸 FDA
Patent

US 8258163

Small-molecule agonists for type-2 orexin receptor

granted A61KA61K31/4168A61K31/496

Quick answer

US patent 8258163 (Small-molecule agonists for type-2 orexin receptor) held by The Board of Regents of the University of Texas System expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Sep 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/4168, A61K31/496, A61K31/506, A61K31/5377